Rituximab for patients with myopathy associated with anti-signal recognition particle antibodies: comment on the article by Valiyil et al.
Deligny
Christophe
C
Goëb
Vincent
V
Dueymes
Maryvonne
M
Kahn
Valentine
V
Dehlinger
Véronique
V
Baptiste
Georges Jean
GJ
Amarof
Khadija
K
Arfi
Serge
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D018908:Muscle Weakness / Q000276:immunology*; D009220:Myositis / Q000276:immunology*; D018271:Signal Recognition Particle / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D018271:Signal Recognition Particle